General Biological

General Biological

Private
New Haven, ConnecticutFrontier & Industrial Techhttps://generalbiological.com/

Last Round

Seed

Dec 1, 2024

Total Funding Raised

$6.63M

Momentum Score

75 /100

Company Overview

General Biological is an industrial biotechnology company developing a biomanufacturing platform to produce specialty chemicals and materials from renewable feedstocks.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Clean Manufacturing, Sustainable Materials, Biotech Equipment, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

biomanufacturing platformcontinuous biomanufacturingsynthetic biologysynbioindustrial biotechnologybio-based chemicalscustom bioreactorsonshoring manufacturingrenewable feedstockssuccinic acid1,4-butanediolBDOC4 chemicalsdefense industrial basetetrahydrofuranTHF

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

General Biological Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

General Biological Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedDec 1, 2024
GrantMar 31, 2023

Key People

Founding team and executive leadership

David Sozanski

CTO, Founder

Founding Team

General Biological Investors

Notable investors and investment history

General Biological Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

General Biological Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about General Biological's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Haven, Connecticut
Employee Range15
Year Founded2023
Last FundingDec 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.